PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc.
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd. (Roche) which resolves all outstanding ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS — PDL BioPharma, Inc., a ...
LOS ANGELES, May 2 (Reuters) - PDL Biopharma Inc. said on Wednesday its first-quarter net loss narrowed on higher sales of acute-care products and better royalty revenue. The company, which also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback